Honest Care is an online service that helps patients denied GLP‑1 medication coverage by collecting their medical and prescription history, then generating a customized appeal letter and supporting evidence report tailored to the insurer’s specific denial reasons. The platform offers a free self‑guided option and paid plans with specialist review, live guidance, and a digital fax center to submit the complete appeal packet, enabling users to pursue coverage with confidence.
Funding
Funding not disclosed
Founders
Product
Problem
Patients prescribed GLP‑1 medications often face insurance denials due to step‑therapy requirements, prior‑authorization rules, or perceived lack of medical necessity, leaving them without access to weight‑loss and diabetes treatments.
Solution
Honest Care provides an online platform that gathers a patient’s medical history, prescription record, and denial details through a structured assessment. Using this information, professional appeal specialists draft a customized appeal letter that addresses the insurer’s specific denial reasons, cites clinical research, and documents prior weight‑loss attempts. The service also generates a supporting evidence report summarizing BMI, comorbidities, and medication history, and offers a digital fax center to transmit the complete appeal packet directly to insurers or physicians. Patients can choose a self‑guided free plan or a paid premium plan that includes live support and step‑by‑step guidance, enabling them to submit appeals with confidence.
Target Audience
Individuals who have been denied coverage for GLP‑1 medications and need assistance preparing an appeal, as well as healthcare providers who wish to submit appeals on behalf of their patients.
Features
- Online assessment that captures health conditions, medication history, and insurance denial details
- Custom‑written appeal letters tailored to the insurer’s prior‑authorization or step‑therapy criteria
- Supporting evidence report aggregating BMI, comorbidities, past weight‑loss attempts, and relevant clinical studies
- Digital fax center that formats and sends the full appeal packet to insurers or doctors without physical paperwork
- Free self‑guided plan with a draft appeal and paid premium plans offering specialist review, live guidance, and full submission support
- Coverage focus on GLP‑1 drugs such as Wegovy, Ozempic, Zepbound, and Mounjaro, with potential expansion to other medications